These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 24373828)
21. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways. Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326 [TBL] [Abstract][Full Text] [Related]
22. Regulation of ATM in DNA double strand break repair accounts for the radiosensitivity in human cells exposed to high linear energy transfer ionizing radiation. Xue L; Yu D; Furusawa Y; Okayasu R; Tong J; Cao J; Fan S Mutat Res; 2009 Nov; 670(1-2):15-23. PubMed ID: 19583974 [TBL] [Abstract][Full Text] [Related]
23. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway. Schweikl H; Petzel C; Bolay C; Hiller KA; Buchalla W; Krifka S Biomaterials; 2014 Mar; 35(9):2890-904. PubMed ID: 24411679 [TBL] [Abstract][Full Text] [Related]
24. Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro. Cui J; Liu J; Wu S; Wang Y; Shen H; Xing L; Wang J; Yan X; Zhang X Arch Toxicol; 2013 Oct; 87(10):1829-40. PubMed ID: 23515941 [TBL] [Abstract][Full Text] [Related]
25. Triphlorethol-a improves the non-homologous end joining and base-excision repair capacity impaired by formaldehyde. Zhang R; Kang KA; Piao MJ; Kim KC; Lee NH; You HJ; Hyun JW J Toxicol Environ Health A; 2011; 74(12):811-21. PubMed ID: 21541882 [TBL] [Abstract][Full Text] [Related]
26. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Denchi EL; de Lange T Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332 [TBL] [Abstract][Full Text] [Related]
27. Relative contribution of homologous recombination and non-homologous end-joining to DNA double-strand break repair after oxidative stress in Saccharomyces cerevisiae. Letavayová L; Marková E; Hermanská K; Vlcková V; Vlasáková D; Chovanec M; Brozmanová J DNA Repair (Amst); 2006 May; 5(5):602-10. PubMed ID: 16515894 [TBL] [Abstract][Full Text] [Related]
28. Effect of gliclazide on nucleotide excision repair (NER) and non-homologous DNA end joining (NHEJ) in normal and cancer cells. Sliwinska A; Sliwinski T; Kasznicki J; Drzewoski J J Physiol Pharmacol; 2010 Jun; 61(3):347-53. PubMed ID: 20610866 [TBL] [Abstract][Full Text] [Related]
29. Non-homologous end-joining, a sticky affair. van Gent DC; van der Burg M Oncogene; 2007 Dec; 26(56):7731-40. PubMed ID: 18066085 [TBL] [Abstract][Full Text] [Related]
30. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Starcevic SL; Diotte NM; Zukowski KL; Cameron MJ; Novak RF Toxicol Sci; 2003 Sep; 75(1):74-81. PubMed ID: 12805649 [TBL] [Abstract][Full Text] [Related]
31. Studying the cerebellar DNA damage response in the tissue culture dish. Tzur-Gilat A; Ziv Y; Mittelman L; Barzilai A; Shiloh Y Mech Ageing Dev; 2013 Oct; 134(10):496-505. PubMed ID: 23583690 [TBL] [Abstract][Full Text] [Related]
32. Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner. Gatz SA; Keimling M; Baumann C; Dörk T; Debatin KM; Fulda S; Wiesmüller L Carcinogenesis; 2008 Mar; 29(3):519-27. PubMed ID: 18174244 [TBL] [Abstract][Full Text] [Related]
33. Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines. Mérel P; Prieur A; Pfeiffer P; Delattre O Oncogene; 2002 Aug; 21(36):5654-9. PubMed ID: 12165865 [TBL] [Abstract][Full Text] [Related]
34. [Double strand break repair, one mechanism can hide another: alternative non-homologous end joining]. Rass E; Grabarz A; Bertrand P; Lopez BS Cancer Radiother; 2012 Feb; 16(1):1-10. PubMed ID: 21737335 [TBL] [Abstract][Full Text] [Related]
35. Physapruin A Enhances DNA Damage and Inhibits DNA Repair to Suppress Oral Cancer Cell Proliferation. Yu TJ; Yen CY; Cheng YB; Yen CH; Jeng JH; Tang JY; Chang HW Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012104 [TBL] [Abstract][Full Text] [Related]
36. Isolation and characterisation of irinans, androstane-type withanolides from Stein A; Compera D; Karge B; Brönstrup M; Franke J Beilstein J Org Chem; 2019; 15():2003-2012. PubMed ID: 31501667 [TBL] [Abstract][Full Text] [Related]
37. Targeting the ataxia telangiectasia mutated pathway for effective therapy against hirsutine-resistant breast cancer cells. Lou C; Yokoyama S; Abdelhamed S; Saiki I; Hayakawa Y Oncol Lett; 2016 Jul; 12(1):295-300. PubMed ID: 27347141 [TBL] [Abstract][Full Text] [Related]
38. Management of triple-negative breast cancer by natural compounds through different mechanistic pathways. Kaleem M; Thool M; Dumore NG; Abdulrahman AO; Ahmad W; Almostadi A; Alhashmi MH; Kamal MA; Tabrez S Front Genet; 2024; 15():1440430. PubMed ID: 39130753 [TBL] [Abstract][Full Text] [Related]
39. Identification of Key Pathways Involved in White Strain of Li WS; Lee KD; Chen LY; You BJ; Lee HZ Front Pharmacol; 2022; 13():888863. PubMed ID: 35784738 [TBL] [Abstract][Full Text] [Related]